Product and Service [Axis] Product Revenue [Member] Grant Revenue [Member] Class of Stock [Axis] Convertible Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Treasury Stock, Common [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Customer [Axis] Customers [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Three Customers [Member] Four Customers [Member] One Granting Agency [Member] Two Customer [Member] Two Granting Agency [Member] Two Customers [Member] Accounts Receivable [Member] Customers Together [Member] Cash and Cash Equivalents [Axis] Cash [Member] US Treasury Securities [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 2 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input Strike Price [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Finite-Lived Intangible Assets by Major Class [Axis] In Process Research and Development [Member] Noncompete Agreements [Member] Geographical [Axis] UNITED STATES Product [Member] Grant [Member] Non-US [Member] Geographic Concentration Risk [Member] Warrant [Member] Antidilutive Securities [Axis] Restricted Stock Units (RSUs) [Member] Plan Name [Axis] 2015 Long Term Incentive Plan [Member] 2025 Long Term Incentive Plan [Member] Award Type [Axis] Share-Based Payment Arrangement, Option [Member] Statement of Income Location, Balance [Axis] Cost of Sales [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Research and Development Expense [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Amended And Restated Equity Distribution Agreement [Member] Equity Distribution Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Securities Purchase Agreement [Member] Title and Position [Axis] Two Institutional Investors [Member] Related and Nonrelated Parties [Axis] CoSara Diagnostics Pvt Ltd [Member] Pre-Funded Warrants [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] Assets Current assets Cash and cash equivalents Marketable investment securities Accounts receivable, net Inventory, net Income taxes receivable Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use asset Intangible assets, net Investment in joint venture Total assets Liabilities and stockholders’ equity Current liabilities Accounts payable Accrued expenses Operating lease liability, current Contingent consideration liabilities, current Deferred revenue Total current liabilities Long-term liabilities Income taxes payable Operating lease liability Contingent consideration liabilities Total long-term liabilities Total liabilities Commitments and contingencies (Note 10) Stockholders’ equity Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively Common stock, $0.001 par value; 100,000,000 shares authorized; 52,991,260 shares issued and 48,142,582 shares outstanding as of September 30, 2025 and 37,902,222 shares issued and 33,053,544 shares outstanding as of December 31, 2024 Treasury stock, at cost; 4,848,678 shares held as of September 30, 2025 and December 31, 2024, respectively Additional paid-in capital Accumulated other comprehensive income Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Convertible preferred stock, par value Convertible preferred stock , shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Statement [Table] Statement [Line Items] Total revenue Cost of revenue Gross profit Operating expenses Sales and marketing General and administrative Research and development Depreciation and amortization Total operating expenses Loss from operations Other income (expense), net Interest income, net Realized gain on investments Gain (loss) on disposition of assets Gain (loss) on remeasurement of acquisition contingencies Gain (loss) on equity method investment in joint venture Total other income (expense), net Loss before income taxes Income tax provision (benefit) Net loss Other comprehensive income (loss) Change in net unrealized gains (losses) on marketable securities, net of tax Total other comprehensive income (loss) Comprehensive loss Loss per common share: Basic Diluted Weighted average shares outstanding: Basic Diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization Stock-based compensation expense Common stock issued for financial advisory services Change in fair value of acquisition contingencies Non-cash lease expense Realized gain on investments Loss from equity method investment (Gain) loss on disposition of assets Provision for credit losses (recoveries of) Inventory obsolescence expense (recovery) Changes in assets and liabilities: Accounts receivable Prepaid expenses and other assets Inventory Deferred revenue Income taxes payable Accounts payable, accrued expenses and other liabilities Net cash used in operating activities Cash flows from investing activities Purchases of property and equipment Proceeds from maturities of marketable investment securities Purchases of marketable securities Investment in joint venture Net cash provided by investing activities Cash flows from financing activities Issuance of common stock related to at-the-market offering, net of offering costs Issuance of common stock related to registered direct offering, net of offering costs Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosure of cash flow information Cash paid (received) for income taxes Balance Balance, shares Issuance of common stock related to at-the-market offering, net of offering costs Issuance of common stock related to at-the-market offering, net of offering costs, shares Stock-based compensation Stock-based compensation, shares Other comprehensive income (loss), net of tax Issuance of common stock related to financial advisory services Issuance of common stock related to financial advisory services, shares Issuance of common stock related to registered direct offering, net of offering costs Issuance of common stock related to financial advisory services, shares Balance Balance, shares Accounting Policies [Abstract] Overview and Basis of Presentation Summary of Significant Accounting Policies Cash and Cash Equivalents [Abstract] Cash, Cash Equivalents, and Financial Instruments Fair Value Disclosures [Abstract] Fair Value Measurements Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets, Net Revenue from Contract with Customer [Abstract] Revenue Earnings Per Share [Abstract] Loss Per Share Share-Based Payment Arrangement [Abstract] Stock-Based Compensation Income Tax Disclosure [Abstract] Income Taxes Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Share Repurchase Program At-the-market Agreement At-the-Market Agreement Registered Direct Offering Registered Direct Offering Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Reclassifications Operating Segments Accounts Receivable Inventory Revenue Recognition Grant Revenue Income Taxes Concentrations Risk and Significant Customers Recently Issued Accounting Standards Schedule of Cash, Cash Equivalents and Marketable Investment Securities Schedule of Fair Value Assets and Liabilities Schedule of Changes in the Fair Value Measurement Schedule of Contingent Consideration Common Stock and Warrants Schedule of Intangible Assets, Net Summary of Revenue by Geographic Area Schedule of Deferred Revenue Schedule of Basis and Diluted Earnings Per Share Schedule of Option Activity Schedule of Outstanding Restricted Stock Units and Related Party Schedule of Warrant Activity Schedule of Recognized Stock-Based Compensation Expense Schedule of Lease Expense Schedule of Maturities on Company Lease Liabilities Schedule of Other Information Related to Operating Leases Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Accounts receivable Allowance for uncollectable accounts Inventory Inventory finished goods Inventory raw materials Inventory reserves Grant funding revenue Deferred revenue Concentration risk percentage Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Line Items] Adjusted Cost Total Unrealized Gains / (Losses) Fair Value Cash and Cash Equivalents Marketable Securities Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Contingent consideration - common stock Total liabilities measured at fair value Cash equivalents Marketable securities (U.S. treasury bills and notes) Total assets measured at fair value Contingent consideration - warrants Fair value as of December 31, 2024 Change in fair value of contingent consideration issued for business acquisitions Fair value as of September 30, 2025 Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Warrants measurement input Expected term Intangible Asset, Finite-Lived [Table] Finite-Lived Intangible Assets [Line Items] Estimated useful lives in years, term Intangible assets, gross Less accumulated amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenue geographic area Percentage of revenue Deferred revenue, beginning balance Revenue recognized included in deferred revenue balance Increase due to prepayments from customers Deferred revenue, ending balance Net loss, as reported Weighted average shares, basic Dilutive effect of stock options, warrants and RSUs Shares used to compute diluted earnings per share Loss per share, basic Loss per share, diluted Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Securities excluded from computation of diluted earnings per share Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of Options Outstanding, Beginning Weighted Average Exercise Price Outstanding, Beginning Weighted Average Fair Value Outstanding, Beginning Weighted-average Remaining Contractual Life (years) Outstanding, Beginning Number of Options Outstanding, Granted Weighted Average Exercise Price, Granted Weighted Average Fair Value, Granted Number of Options Outstanding, Expired Weighted Average Exercise Price, Expired Weighted Average Fair Value, Expired Number of Options Outstanding, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Fair Value, Forfeited/Cancelled Number of Options Outstanding, Exercised Weighted Average Exercise Price, Exercised Weighted Average Fair Value, Exercised Number of Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Ending Weighted Average Fair Value Outstanding, Ending Number of Options Exercisable Ending Weighted Average Exercise Price, Exercisable Ending Weighted Average Fair Value, Exercisable Ending Weighted-average Remaining Contractual Life (years), Exercisable Ending Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Restricted Stock Units, Outstanding Beginning Weighted Average Grant Date Fair Value, Outstanding Beginning Number of Restricted Stock Units, Granted Weighted Average Grant Date Fair Value, Granted Number of Restricted Stock Units, Vested Weighted Average Grant Date Fair Value, Vested Number of Restricted Stock Units, Forfeited/Cancelled Weighted Average Grant Date Fair Value, Forfeited/Cancelled Number of Restricted Stock Units, Outstanding Ending Weighted Average Grant Date Fair Value, Outstanding Ending Number of Warrants Outstanding, Beginning Weighted Average Exercise Price, Beginning Weighted Average fair value, Beginning Weighted-average Remaining Contractual Life (Years) Outstanding Number of Warrants Outstanding, Granted Weighted Average Exercise Price, Granted Weighted Average Fair Value, Granted Number of Warrants Outstanding, Expired Weighted Average Exercise Price, Expired Weighted Average Fair Value, Expired Number of Warrants Outstanding, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Fair Value, Forfeited/Cancelled Number of Warrants Outstanding, Exercised Weighted Average Exercise Price, Exercised Weighted Average Fair Value, Exercised Number of Warrants Outstanding, Ending Weighted Average Exercise Price, Ending Weighted Average Fair Value, Ending Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Total stock-based compensation expense Number of common shares available for issuance Intrinsic value of outstanding warrants Unrecognized stock-based compensation Stock based compensation expense related to weighted average period Warrants exercisable Warrants to purchase a common stock Income tax expense (benefit) Effective income tax rate reconciliation, percent Effective income tax rate reconciliation, statutory rate Income tax expense (benefit) Operating lease costs Short-term lease costs Total lease costs 2025 (remainder) 2026 2027 2028 Total lease payments Less: imputed interest Present value of operating lease liabilities Less: current portion Long-term portion Cash paid for operating leases included in operating cash flows Remaining lease term of operating leases Discount rate of operating leases Stock repurchase program authorized amount Stock repurchased during period, shares AtTheMarketAgreementTable [Table] AtTheMarketAgreementLineItems [Line Items] Proceeds from offering Shares issued Net proceeds Common stock par value RegisteredDirectOfferingTable [Table] RegisteredDirectOfferingLineItems [Line Items] Number of shares Offering price per shares Gross proceeds Placement agent fees percentage Legal counsel fees Related Party Transaction [Table] Related Party Transaction [Line Items] Research and development expenses Subsequent Event [Table] Subsequent Event [Line Items] Stock Issued During Period, Shares, Other Common Stock, Par or Stated Value Per Share Shares Issued, Price Per Share Stock Issued During Period, Shares, New Issues Class of Warrant or Right, Exercise Price of Warrants or Rights Stock Issued During Period, Value, New Issues [custom:PlacementAgentFeesPercentage] Legal Fees Taxes payable non current. Gain loss on remeasurement of acquisition contingencies. Common stock issued for financial advisory services. Gain on remeasurement of acquisition contingencies. Noncash lease expense. Proceeds from issuance of direct offering. Change in inventory reserves. Grant Revenue [Policy Text Block] Grant Funding Revenue. Customers [Member] Two Customers [Member] Four Customers [Member] Two Granting Agency [Member] One Granting Agency [Member] Two Customer [Member] Customers Together [Member] Fair value of contingent consideration to common stock. Fair value of contigent consideration to warrants. Contingent considered issued for business acquisitions. Measurement Input Strike Price [Member] Indefinite lived intangible asset useful life. Increase due to prepayments from customers. 2015 Long Term Incentive Plan [Member] 2025 Long Term Incentive Plan [Member] Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercised. Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercisable. Weighted average exercise price, beginning. Weighted average exercise price granted. Sharebased compensation arrangements by sharebased payment award nonoptions expired in period weighted average exercise price. Weighted average exercise price, forfeited/cancelled. Sharebased compensation arrangements by sharebased payment award nonoptions exercised in period weighted average exercise price. Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan. Share based compensation arrangement by share based payment award non options outstanding weighted average fair value. Weighted average grant date fair value, granted Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercised. Sharebased compensation arrangements by sharebased payment award options nonvested nonoptions forfeitures weighted average grant date fair value. Sharebased compensation arrangements by sharebased payment award options nonvested nonoptions exercised weighted average grant date fair value. Weighted average fair value, beginning. Weighted-average remaining contractual life (years) outstanding, beginning. Class of warrant exercisable. Schedule of Operating Lease [Table Text Block] The entire disclosure for at-the-market agreement. ATM Agreement [Member] Piper Sandler & Co. [Member] CoSara Diagnostics Pvt Ltd [Member] Registered Direct Offering [Disclosure Text Block] Securities Purchase Agreement [Member] Two Institutional Investors [Member] Placement agent fees percentage. Pre-Funded Warrants [Member] Product Revenue [Member] Grant Revenue [Member] Assets, Current Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Other Comprehensive Income (Loss), before Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Depreciation, Depletion and Amortization GainOnRemeasurementOfAcquisitionContingencies Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Income Taxes Payable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment Payments to Acquire Marketable Securities Payments to Acquire Interest in Joint Venture Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Shares, Outstanding RegisteredDirectOfferingDisclosureTextBlock Income Tax, Policy [Policy Text Block] Deferred Revenue Business Combination, Contingent Consideration, Liability, Noncurrent Contract with Customer, Liability Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueExercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageFairValue ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsGrantedWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsExpirationsWeightedAverageGrantDateFairValue ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeituresWeightedAverageGrantDateFairValue ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsExercisedWeightedAverageGrantDateFairValue ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonOutstandingWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValue Lease, Cost Lessee, Operating Lease, Liability, to be Paid